Barbara G.
- Country
- Poland
- Department
- Oddział Hematologii
Research Overview
- A Randomized, Multi-Center, Parallel, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® plus Standard Medical Treatment Compared to Placebo plus Standard Medical Treatment to Prevent Infections in Patients with Hypogammaglobulinemia and Recurrent or Severe Infections Associated with B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- A Phase 2 Open-label Clinical Study to Evaluate the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma(waveLINE-004)
Data & Insights
Has run more than one trial at 1 of 65 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating complex hematologic malignancies, with particular emphasis on B-cell lymphoproliferative disorders. Their research encompasses innovative therapeutic approaches for patients with challenging blood cancers.
- Chronic Lymphocytic Leukemia (CLL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Multiple Myeloma
Their work extends to managing complications in immunocompromised patients with these conditions.
Immunotherapy Research
The investigator focuses on developing and evaluating novel immunotherapeutic approaches for treating resistant forms of lymphoma. Their expertise includes investigating targeted therapies for patients who have not responded to conventional treatments.
- Antibody-Based Therapies
- Immune System Enhancement
- Treatment-Resistant Disease
Their research includes exploring combination approaches with standard medical treatments.
Supportive Care Medicine
The investigator has developed expertise in managing immunodeficiency complications in cancer patients, particularly focusing on hypogammaglobulinemia associated with hematologic malignancies.
- Infection Prevention
- Immune System Support
- Quality of Life Enhancement
Their work includes evaluating preventive strategies for reducing infection risks in immunocompromised patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.